Iovance Biotherapeutics, Inc. (IOVA) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$2,176
Total Return
-78.24%
CAGR
-26.29%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +0.12% |
| Median | -4.98% |
| Best | +130.17% |
| Worst | -61.07% |
| % of Windows Positive | 40.0% |
1-Year (252 Trading Days)
| Average | -18.44% |
| Median | -48.33% |
| Best | +208.86% |
| Worst | -87.48% |
| % of Windows Positive | 30.6% |
3-Year (756 Trading Days)
| Average | -64.68% |
| Median | -64.44% |
| Best | -25.75% |
| Worst | -89.39% |
| % of Windows Positive | 0.0% |
Risk Metrics
| Maximum Drawdown | -93.99% |
| Average Drawdown | -65.91% |
| Drawdown Duration | 1161 Trading Days (Unrecovered) |
| Sortino Ratio | 0.19 |
| Calmar Ratio | -0.28 |
| CVaR (5%) | -11.17% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +38.83% (+117.73% ann.) | +$3882.78 | $0.00 | $0.00 | $0.00 |
| 2025 | -63.11% | $6310.81 | $0.00 | $0.00 | $0.00 |
| 2024 | -8.98% | $897.91 | $0.00 | $0.00 | $0.00 |
| 2023 | +27.23% | +$2723.00 | $0.00 | $0.00 | $0.00 |
| 2022 | -66.53% | $6652.70 | $0.00 | $0.00 | $0.00 |
| 2021 | -58.86% | $5885.78 | $0.00 | $0.00 | $0.00 |
| 2020 | +67.63% | +$6763.01 | $0.00 | $0.00 | $0.00 |
| 2019 | +212.77% | +$21276.84 | $0.00 | $0.00 | $0.00 |
| 2018 | +10.62% | +$1062.50 | $0.00 | $0.00 | $0.00 |
| 2017 | +15.11% | +$1510.79 | $0.00 | $0.00 | $0.00 |
| 2016 | -9.97% | $997.41 | $0.00 | $0.00 | $0.00 |
| 2015 | -1.91% | $190.60 | $0.00 | $0.00 | $0.00 |
| 2014 | -25.05% | $2504.76 | $0.00 | $0.00 | $0.00 |
| 2013 partial | +950.00% (+3591.33% ann.) | +$95000.00 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | May 7, 2013 – February 19, 2020 | +2389.00% | +60.58% | +$238899.99 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -4.30% | -39.45% | $430.06 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +25.82% | +44.72% | +$2582.45 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -53.42% | -51.56% | $5342.19 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -58.12% | -60.31% | $5811.97 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +20.18% | +10.43% | +$2018.45 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -62.73% | -43.94% | $6273.35 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.